RNA Interference Therapy With ARC‐520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection

BACKGROUND AND AIMS: ARC‐520, the first an RNA interference (RNAi) therapeutic, was designed to reduce all RNA transcripts derived from covalently closed circular DNA, leading to a reduction in viral antigens and hepatitis B virus (HBV) DNA. APPROACH AND RESULTS: We aimed to evaluate the depth of he...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuen, Man‐Fung, Schiefke, Ingolf, Yoon, Jung‐Hwan, Ahn, Sang Hoon, Heo, Jeong, Kim, Ju Hyun, Lik Yuen Chan, Henry, Yoon, Ki Tae, Klinker, Hartwig, Manns, Michael, Petersen, Joerg, Schluep, Thomas, Hamilton, James, Given, Bruce D., Ferrari, Carlo, Lai, Ching‐Lung, Locarnini, Stephen A., Gish, Robert G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496196/
https://www.ncbi.nlm.nih.gov/pubmed/31654573
http://dx.doi.org/10.1002/hep.31008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496196/
https://www.ncbi.nlm.nih.gov/pubmed/31654573
http://dx.doi.org/10.1002/hep.31008

Ejemplares similares